Clinical Trials Directory

Trials / Completed

CompletedNCT05529381

Anxiety and Depressive Symptoms in Placenta Previa / Accreta

Anxiety and Depressive Symptoms of Pregnant Women Diagnosed to Have Placenta Previa / Accreta

Status
Completed
Phase
Study type
Observational
Enrollment
73 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

placenta previa is an obstetric complication which is associated with depression and anxiety. As little is known about the emotional reaction to the diagnosis of placenta previa/accrete, a study is badly needed to estimate the magnitude of this problem and its effects on the mother

Detailed description

Placenta previa is an obstetric complication with a prevalence of 5.2 per 1000 pregnancies. placenta previa is associated with maternal morbidity and mortality. The delivery carries a risk of bleeding, emergency hysterectomy, organ damage and even death. During admission, counselling is done for the possible need for delivery at any time and the need for life saving hysterectomy. hysterectomy is a tough and difficult choice for patients, and the subsequent emotional process is often associated with depression, severe and prolonged feelings of sadness, diminished interest in activities and in sexual intercourse. Similarly, severe adverse psychological outcomes, including post-traumatic stress disorders, have been reported as a result of traumatic birth events. Antenatal depression and anxiety occur in approximately 13% and up to 21.7% of women, respectively. Rates of antenatal depression among women hospitalized for obstetrical risk can be as high as 19%. Research about the responses to a diagnosis of placenta previa is scarce. A study found increased anxiety score in women diagnosed with Placenta accreta spectrum. Other studies focussed on the post-trauma stress associated with hysterectomy versus uterine conservation. As little is known about the emotional reaction to the diagnosis of placenta previa/accrete, a study is badly needed to estimate the magnitude of this problem and its effects on the mother.

Conditions

Timeline

Start date
2022-11-26
Primary completion
2024-06-06
Completion
2024-11-06
First posted
2022-09-07
Last updated
2024-11-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05529381. Inclusion in this directory is not an endorsement.